Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 1,401–1,448 of 1,448 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01033981	Cost Effectiveness Of Sunitinib In Central America And Caribbean	terminated	—	4	PfizerINDUSTRY	1	Apr 19, 2012	clinicaltrials
NCT01075607	Lymph Fluid and Blood Collection for Identification of Novel Biomarkers	terminated	—	50	Indiana UniversityOTHER	1	Mar 28, 2012	clinicaltrials